Cannabinoids in pediatrics

Christopher T. Campbell, Marjorie Shaw Phillips, Kalen B. Manasco

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. Many providers have started encountering patients experimenting with cannabis products for a wide range of conditions. While the debate continues regarding these agents for both medicinal and recreational use in the general population, special consideration needs to be made for pediatric use. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.

Original languageEnglish (US)
Pages (from-to)176-185
Number of pages10
JournalJournal of Pediatric Pharmacology and Therapeutics
Volume22
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Medical Marijuana
Cannabinoids
Cannabis
Pediatrics
Legislation
Cannabidiol
Health Personnel
Parents
History
Population

Keywords

  • CBD
  • Cannabidiol
  • Cannabis
  • Epilepsy
  • Pediatrics
  • Pharmacy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)

Cite this

Campbell, C. T., Phillips, M. S., & Manasco, K. B. (2017). Cannabinoids in pediatrics. Journal of Pediatric Pharmacology and Therapeutics, 22(3), 176-185. https://doi.org/10.5863/1551-6776-22.3.176

Cannabinoids in pediatrics. / Campbell, Christopher T.; Phillips, Marjorie Shaw; Manasco, Kalen B.

In: Journal of Pediatric Pharmacology and Therapeutics, Vol. 22, No. 3, 01.05.2017, p. 176-185.

Research output: Contribution to journalReview article

Campbell, CT, Phillips, MS & Manasco, KB 2017, 'Cannabinoids in pediatrics', Journal of Pediatric Pharmacology and Therapeutics, vol. 22, no. 3, pp. 176-185. https://doi.org/10.5863/1551-6776-22.3.176
Campbell, Christopher T. ; Phillips, Marjorie Shaw ; Manasco, Kalen B. / Cannabinoids in pediatrics. In: Journal of Pediatric Pharmacology and Therapeutics. 2017 ; Vol. 22, No. 3. pp. 176-185.
@article{e700e19e8de04c9b84d69065da6ce32d,
title = "Cannabinoids in pediatrics",
abstract = "Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. Many providers have started encountering patients experimenting with cannabis products for a wide range of conditions. While the debate continues regarding these agents for both medicinal and recreational use in the general population, special consideration needs to be made for pediatric use. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.",
keywords = "CBD, Cannabidiol, Cannabis, Epilepsy, Pediatrics, Pharmacy",
author = "Campbell, {Christopher T.} and Phillips, {Marjorie Shaw} and Manasco, {Kalen B.}",
year = "2017",
month = "5",
day = "1",
doi = "10.5863/1551-6776-22.3.176",
language = "English (US)",
volume = "22",
pages = "176--185",
journal = "Journal of Pediatric Pharmacology and Therapeutics",
issn = "1551-6776",
publisher = "Pediatric Pharmacology Advocacy Group, Inc.",
number = "3",

}

TY - JOUR

T1 - Cannabinoids in pediatrics

AU - Campbell, Christopher T.

AU - Phillips, Marjorie Shaw

AU - Manasco, Kalen B.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. Many providers have started encountering patients experimenting with cannabis products for a wide range of conditions. While the debate continues regarding these agents for both medicinal and recreational use in the general population, special consideration needs to be made for pediatric use. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.

AB - Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. Many providers have started encountering patients experimenting with cannabis products for a wide range of conditions. While the debate continues regarding these agents for both medicinal and recreational use in the general population, special consideration needs to be made for pediatric use. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.

KW - CBD

KW - Cannabidiol

KW - Cannabis

KW - Epilepsy

KW - Pediatrics

KW - Pharmacy

UR - http://www.scopus.com/inward/record.url?scp=85040966980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040966980&partnerID=8YFLogxK

U2 - 10.5863/1551-6776-22.3.176

DO - 10.5863/1551-6776-22.3.176

M3 - Review article

AN - SCOPUS:85040966980

VL - 22

SP - 176

EP - 185

JO - Journal of Pediatric Pharmacology and Therapeutics

JF - Journal of Pediatric Pharmacology and Therapeutics

SN - 1551-6776

IS - 3

ER -